Maple Leaf

viDA Therapeutics

About viDA Therapeutics

Location: Vancouver | British Columbia

Industry Focus: Healthcare  

Subsectors: Biotechnology 

viDA Therapeutics is developing a library of first in class serine protease inhibitors focusing on a new mechanism of action for extracellular Granzyme B in chronic inflammatory, autoimmune, and age-related indications.

Alistair Duncan

President & CEO

Get in Touch with viDA Therapeutics

* indicates required